The decision by a Texas judge to overturn F.D.A. approval for the abortion pill mifepristone could upend the pharmaceutical industry. Story Published at: April 11, 2023 at 01:01PM Continue Reading…
Why Drugmakers’ Battle in Texas is Such a Big Deal
Markets Climb as Silicon Valley Bank Finally Finds a Buyer
First Citizens agreed on Sunday to acquire the failed lender’s retail operations, a move that will cost taxpayers but is reassuring investors. Story Published at: March 27, 2023 at 12:51PM Continue Reading…
A Recession Warning Spooks the Market
Investors were alarmed at suggestions by Jerome Powell, the Federal Reserve’s chairman, that interest rates could go even higher in a bid to halt inflation. Story Published at: March 8, 2023 at 01:21PM Continue Reading…
A Mega Airline Merger Hits Turbulence
Regulators looking to block JetBlue’s $3.8 billion bid to buy Spirit Airways think there’s no other way to address their competition concerns. Story Published at: March 7, 2023 at 12:35PM Continue Reading…
Reshaping Corporate America with Billions in Giveaways
Big strings are attached to funding for chip makers, meant to bolster Democratic priorities including child care for workers and discouragement of stock buybacks. Story Published at: February 28, 2023 at 12:52PM Continue Reading…
Dissecting Elon Musk’s Tweets: Memes, Rants, Private Parts and Echo Chamber
As he fights for free speech online and promotes his companies, the new owner of Twitter spends a lot of time replying to his fans. Story Published at: February 1, 2023 at 01:11AM Continue Reading…
Tesla Bulls Are Back at the Wheel
Shares in the electric carmaker continued to rally after the company reported strong profits, even amid growing competition and economic pressures. Story Published at: January 26, 2023 at 12:36PM Continue Reading…
A Short Seller Takes Aim at an Indian Corporate Giant
Hindenburg Research accused the Adani Group of orchestrating the “largest con in corporate history,” sending shares of its companies tumbling on Wednesday. Story Published at: January 25, 2023 at 01:14PM Continue Reading…
Live Nation Faces a Skeptical Senate
The company’s grip on ticket sales, and its move last year to cancel sales for Taylor Swift’s upcoming tour, will be a big focus of an antitrust-focused hearing. Story Published at: January 24, 2023 at 12:44PM Continue Reading…
Why Some Executives Wish E.S.G. ‘Just Goes Away’
The environmental, social and corporate governance investment trend is booming, but it has also become a big distraction for business leaders. Story Published at: January 19, 2023 at 01:04PM Continue Reading…